NewLink Genetics Corp (NASDAQ:NLNK)

4.54
Delayed Data
As of Apr 23
 +0.05 / +1.11%
Today’s Change
3.75
Today|||52-Week Range
19.47
-44.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line102.9M-40.4M-85.2M-72.0M
 
 
 
 
 
Depreciation1.1M1.6M2.1M1.4M
 
 
 
 
 
Total Other Cash Flow8.6M15.9M20.3M18.6M
 
 
 
 
 
Funds From Operations112.6M-22.8M-62.8M-51.9M
 
 
 
 
 
Funds From/For Other Operating Expenses3.5M1.2M3.1M-3.6M
 
 
 
 
 
Net Cash Flow - Operating Activities109.1M-24.1M-65.9M-48.3M
 
 
 
 
 
 
InvestingIncrease In Investments-17.4M0.000.000.00
 
 
Decrease In Investments5.2M10.2M2.2M0.00
 
 
 
 
Capital Expenditures-1.7M-4.0M-2.2M-43.0K
 
 
 
 
 
Fixed Asset Disposal0.00----254.0K
 
 
Net Cash Flow Investing-13.8M6.2M-66.0K211.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings97.0K0.000.00--
 
 
Long Term Debt Reduction-187.0K-194.0K-257.0K-246.0K
 
 
 
 
 
Net Proceeds Stock Sale34.2M23.8M2.2M75.8M
 
 
 
 
 
Common Preferred Redeemed-222.0K-561.0K-82.0K-289.0K
 
 
 
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing33.9M23.1M1.9M75.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash129.1M5.2M-64.1M27.2M